dostęp otwarty

Tom 16, Nr 4 (2019)
Zaburzenia rytmu serca
Opublikowany online: 2019-11-05
Pobierz cytowanie

Podsumowanie wskazań do implantacji układów stymulujących serce

Roman Załuska, Marcin Bobruk, Marcin Bobruk, Marcin Grabowski, Marcin Bobruk
DOI: 10.5603/ChSiN.2019.0041
·
Choroby Serca i Naczyń 2019;16(4):248-256.

dostęp otwarty

Tom 16, Nr 4 (2019)
Zaburzenia rytmu serca
Opublikowany online: 2019-11-05

Streszczenie

Nieprzerwany rozwój gamy dostępnych urządzeń do stałej stymulacji serca wymaga coraz precyzyjniejszej diagnostyki na etapie doboru właściwej metody stymulacji zależnie od schorzenia, objawów, skuteczności i ryzyka powikłań. Autorzy dokonują przeglądu obecnego stanu literatury oraz zalecań dla szczególnych grup pacjentów. W kontekście przedstawionych wyników i własnych doświadczeń autorzy wskazują mikrostymulatory jako urządzenia, które mogą być przyszłością stałej stymulacji serca.

Streszczenie

Nieprzerwany rozwój gamy dostępnych urządzeń do stałej stymulacji serca wymaga coraz precyzyjniejszej diagnostyki na etapie doboru właściwej metody stymulacji zależnie od schorzenia, objawów, skuteczności i ryzyka powikłań. Autorzy dokonują przeglądu obecnego stanu literatury oraz zalecań dla szczególnych grup pacjentów. W kontekście przedstawionych wyników i własnych doświadczeń autorzy wskazują mikrostymulatory jako urządzenia, które mogą być przyszłością stałej stymulacji serca.

Pobierz cytowanie

Słowa kluczowe

stymulacja mięśnia sercowego, bradyarytmia, bradykardia, omdlenia, mechanizm kardiodepresyjny

Informacje o artykule
Tytuł

Podsumowanie wskazań do implantacji układów stymulujących serce

Czasopismo

Choroby Serca i Naczyń

Numer

Tom 16, Nr 4 (2019)

Strony

248-256

Data publikacji on-line

2019-11-05

DOI

10.5603/ChSiN.2019.0041

Rekord bibliograficzny

Choroby Serca i Naczyń 2019;16(4):248-256.

Słowa kluczowe

stymulacja mięśnia sercowego
bradyarytmia
bradykardia
omdlenia
mechanizm kardiodepresyjny

Autorzy

Roman Załuska
Marcin Bobruk
Marcin Bobruk
Marcin Grabowski
Marcin Bobruk

Referencje (87)
  1. Brignole M, Moya A, de Lange FJ, et al. Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) ds. rozpoznawania i leczenia omdleń. Wytyczne ESC dotyczące rozpoznawania i leczenia omdleń (2018). Kardiol Pol. 2018; 76(8): 1119–1198.
  2. Sarasin FP, Hanusa BH, Perneger T, et al. A risk score to predict arrhythmias in patients with unexplained syncope. Acad Emerg Med. 2003; 10(12): 1312–1317.
  3. Quinn J, McDermott D, Stiell I, et al. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006; 47(5): 448–454.
  4. Middlekauff HR, Stevenson WG, Stevenson LW, et al. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol. 1993; 21(1): 110–116.
  5. Brembilla-Perrot B, Suty-Selton C, Beurrier D, et al. Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing. J Am Coll Cardiol. 2004; 44(3): 594–601.
  6. Steinberg JS, Beckman K, Greene HL, et al. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol. 2001; 12(9): 996–1001.
  7. Pezawas T, Stix G, Kastner J, et al. Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantable cardioverter defibrillator therapy. Europace. 2003; 5(3): 305–312.
  8. Olshansky B, Poole JE, Johnson G, et al. SCD-HeFT Investigators. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. J Am Coll Cardiol. 2008; 51(13): 1277–1282.
  9. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association, American College of Cardiology Foundation, Heart Rhythm Society. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol. 2008; 52(14): 1179–1199.
  10. Del Rosso A, Alboni P, Brignole M, et al. Relation of clinical presentation of syncope to the age of patients. Am J Cardiol. 2005; 96(10): 1431–1435.
  11. Martin TP, Hanusa BH, Kapoor WN. Risk stratification of patients with syncope. Ann Emerg Med. 1997; 29(4): 459–466.
  12. Colivicchi F, Ammirati F, Melina D, et al. OESIL (Osservatorio Epidemiologico sulla Sincope nel Lazio) Study Investigators. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J. 2003; 24(9): 811–819.
  13. Del Rosso A, Ungar A, Maggi R, et al. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart. 2008; 94(12): 1620–1626.
  14. Mittal S, Hao SC, Iwai S, et al. Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope. J Am Coll Cardiol. 2001; 38(2): 371–376.
  15. Del Rosso A, Alboni P, Brignole M, et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 2001; 37(7): 1921–1928.
  16. Berecki-Gisolf J, Sheldon A, Wieling W, et al. Identifying cardiac syncope based on clinical history: a literature-based model tested in four independent datasets. PLoS One. 2013; 8(9): e75255.
  17. Locati ET, Moya A, Oliveira M, et al. External prolonged electrocardiogram monitoring in unexplained syncope and palpitations: results of the SYNARR-Flash study. Europace. 2016; 18(8): 1265–1272.
  18. Linzer M, Pritchett EL, Pontinen M, et al. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol. 1990; 66(2): 214–219.
  19. Schuchert A, Maas R, Kretzschmar C, et al. Diagnostic yield of external electrocardiographic loop recorders in patients with recurrent syncope and negative tilt table test. Pacing Clin Electrophysiol. 2003; 26(9): 1837–1840.
  20. Da Costa A, Defaye P, Romeyer-Bouchard C, et al. Clinical impact of the implantable loop recorder in patients with isolated syncope, bundle branch block and negative workup: a randomized multicentre prospective study. Arch Cardiovasc Dis. 2013; 106(3): 146–154.
  21. Brignole M, Menozzi C, Moya A, et al. International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation. 2001; 104(17): 2045–2050.
  22. Moya A, García-Civera R, Croci F, et al. Bradycardia detection in Bundle Branch Block (B4) study. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J. 2011; 32(12): 1535–1541.
  23. Zaidi A, Clough P, Cooper P, et al. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol. 2000; 36(1): 181–184.
  24. Ho RT, Wicks T, Wyeth D, et al. Generalized tonic-clonic seizures detected by implantable loop recorder devices: diagnosing more than cardiac arrhythmias. Heart Rhythm. 2006; 3(7): 857–861.
  25. Petkar S, Hamid T, Iddon P, et al. Prolonged implantable electrocardiographic monitoring indicates a high rate of misdiagnosis of epilepsy--REVISE study. Europace. 2012; 14(11): 1653–1660.
  26. Maggi R, Rafanelli M, Ceccofiglio A, et al. Additional diagnostic value of implantable loop recorder in patients with initial diagnosis of real or apparent transient loss of consciousness of uncertain origin. Europace. 2014; 16(8): 1226–1230.
  27. Farwell DJ, Freemantle N, Sulke N, et al. Use of implantable loop recorders in the diagnosis and management of syncope. Eur Heart J. 2004; 25(14): 1257–1263.
  28. Krahn AD, Klein GJ, Yee R, et al. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001; 104(1): 46–51.
  29. Edvardsson N, Garutti C, Rieger G, et al. PICTURE Study Investigators. Unexplained syncope: implications of age and gender on patient characteristics and evaluation, the diagnostic yield of an implantable loop recorder, and the subsequent treatment. Clin Cardiol. 2014; 37(10): 618–625.
  30. Edvardsson N, Wolff C, Tsintzos S, et al. Costs of unstructured investigation of unexplained syncope: insights from a micro-costing analysis of the observational PICTURE registry. Europace. 2015; 17(7): 1141–1148.
  31. Drak-Hernández Y, Toquero-Ramos J, Fernández JM, et al. Effectiveness and safety of remote monitoring of patients with an implantable loop recorder. Rev Esp Cardiol (Engl Ed). 2013; 66(12): 943–948.
  32. Furukawa T, Maggi R, Bertolone C, et al. Effectiveness of remote monitoring in the management of syncope and palpitations. Europace. 2011; 13(3): 431–437.
  33. Rothman SA, Laughlin JC, Seltzer J, et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol. 2007; 18(3): 241–247.
  34. Woelfel AK, Simpson RJ, Gettes LS, et al. Exercise-induced distal atrioventricular block. J Am Coll Cardiol. 1983; 2(3): 578–581.
  35. Byrne JM, Marais HJ, Cheek GA. Exercise-induced complete heart block in a patient with chronic bifascicular block. J Electrocardiol. 1994; 27(4): 339–342.
  36. Aste M, Oddone D, Donateo P, et al. Syncope in patients paced for atrioventricular block. Europace. 2016; 18(11): 1735–1739.
  37. Sumiyoshi M, Nakata Y, Yasuda M, et al. Clinical and electrophysiologic features of exercise-induced atrioventricular block. Am Heart J. 1996; 132(6): 1277–1281.
  38. Wissocq L, Ennezat PV, Mouquet F. Exercise-induced high-degree atrioventricular block. Arch Cardiovasc Dis. 2009; 102(10): 733–735.
  39. McAnulty JH, Rahimtoola SH, Murphy E, et al. Natural history of high-risk bundle-branch block. N Engl J Med. 1982; 307(3): 137–143.
  40. Moya A, García-Civera R, Croci F, et al. Bradycardia detection in Bundle Branch Block (B4) study. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J. 2011; 32(12): 1535–1541.
  41. Kalscheur MM, Donateo P, Wenzke KE, et al. Long-term outcome of patients with bifascicular block and unexplained syncope following cardiac pacing. Pacing Clin Electrophysiol. 2016; 39(10): 1126–1131.
  42. Krahn AD, Klein GJ, Yee R, et al. The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation. 1995; 92(7): 1819–1824.
  43. Brignole M, Auricchio A, de Lange FJ, et al. Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw stymulacji serca i terapii resynchronizującej we współpracy z European Heart Rhythm Association (EHRA). Wytyczne ESC dotyczące stymulacji serca i terapii resynchronizującej w 2013 roku. Kardiol Pol. 2013; 71(Suppl V): 133–192.
  44. Olshansky B, Hahn EA, Hartz VL, et al. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators. Am Heart J. 1999; 137(5): 878–886.
  45. Moya A, García-Civera R, Croci F, et al. Bradycardia detection in Bundle Branch Block (B4) study. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J. 2011; 32(12): 1535–1541.
  46. Gronda M, Magnani A, Occhetta E, et al. Electrophysiological study of atrio-ventricular block and ventricular conduction defects. Prognostic and therapeutical implications. G Ital Cardiol. 1984; 14(10): 768–773.
  47. Bergfeldt L, Edvardsson N, Rosenqvist M, et al. Atrioventricular block progression in patients with bifascicular block assessed by repeated electrocardiography and a bradycardia-detecting pacemaker. Am J Cardiol. 1994; 74(11): 1129–1132.
  48. Kaul U, DEV V, NARULA J, et al. Evaluation of patients with bundle branch block and “unexplained” syncope: a study based on comprehensive electrophysiologic testing and ajmaline stress. Pacing Clin Electrophysiol. 1988; 11(3): 289–297.
  49. Kalscheur MM, Donateo P, Wenzke KE, et al. Long-term outcome of patients with bifascicular block and unexplained syncope following cardiac pacing. Pacing Clin Electrophysiol. 2016; 39(10): 1126–1131.
  50. Scheinman MM, Peters RW, Suavé MJ, et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol. 1982; 50(6): 1316–1322.
  51. Dhingra RC. Sinus node dysfunction. Pacing Clin Electrophysiol. 1983; 6(5 Pt 2): 1062–1069.
  52. Gann D, Tolentino A, Samet P. Electrophysiologic evaluation of elderly patients with sinus bradycardia: a long-term follow-up study. Ann Intern Med. 1979; 90(1): 24–29.
  53. Menozzi C, Brignole M, Alboni P, et al. The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavorable outcome. Am J Cardiol. 1998; 82(10): 1205–1209.
  54. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015; 36(41): 2793–2867.
  55. Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al. American College of Cardiology, American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines. Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation. 2003; 108(15): 1871–1909.
  56. Alboni P, Menozzi C, Brignole M, et al. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial. Circulation. 1997; 96(1): 260–266.
  57. Breivik K, Ohm OJ, Segadal L. Sick sinus syndrome treated with permanent pacemaker in 109 patients. A follow-up study. Acta Med Scand. 1979; 206(3): 153–159.
  58. Härtel G, Talvensaari T. Treatment of sinoatrial syndrome with permanent cardiac pacing in 90 patients. Acta Med Scand. 1975; 198(5): 341–347.
  59. Rasmussen K. Chronic sinus node disease: natural course and indications for pacing. Eur Heart J. 1981; 2(6): 455–459.
  60. Sasaki Y, Shimotori M, Akahane K, et al. Long-term follow-up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups. Pacing Clin Electrophysiol. 1988; 11(11 Pt 1): 1575–1583.
  61. Brignole M, Arabia F, Ammirati F, et al. Syncope Unit Project 2 (SUP 2) investigators. Standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncope: 3-year insights from the Syncope Unit Project 2 (SUP 2) study. Europace. 2016; 18(9): 1427–1433.
  62. Brignole M, Menozzi C. The natural history of carotid sinus syncope and the effect of cardiac pacing. Europace. 2011; 13(4): 462–464.
  63. Gaggioli G, Brignole M, Menozzi C, et al. A positive response to head-up tilt testing predicts syncopal recurrence in carotid sinus syndrome patients with permanent pacemakers. Am J Cardiol. 1995; 76(10): 720–722.
  64. Deharo JC, Guieu R, Mechulan A, et al. Syncope without prodromes in patients with normal heart and normal electrocardiogram: a distinct entity. J Am Coll Cardiol. 2013; 62(12): 1075–1080.
  65. Brignole M, Deharo JC, De Roy L, et al. Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol. 2011; 58(2): 167–173.
  66. Brignole M, Guieu R, Tomaino M, et al. Mechanism of syncope without prodromes with normal heart and normal electrocardiogram. Heart Rhythm. 2017; 14(2): 234–239.
  67. Brignole M, Menozzi C, Moya A, et al. International Study on Syncope of Uncertain Etiology 3 (ISSUE-3) Investigators. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation. 2012; 125(21): 2566–2571.
  68. Puggioni E, Guiducci V, Brignole M, et al. Results and complications of the carotid sinus massage performed according to the. Am J Cardiol. 2002; 89(5): 599–601.
  69. Sutton R, Brignole M, Menozzi C, et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation. 2000; 102(3): 294–299.
  70. Ammirati F, Colivicchi F, Santini M, et al. Syncope Diagnosis and Treatment Study Investigators. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation. 2001; 104(1): 52–57.
  71. Barón-Esquivias G, Moya-Mitjans A, Martinez-Alday J, et al. Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study. J Am Coll Cardiol. 2017; 70(14): 1720–1728.
  72. Flammang D, Church TR, De Roy L, et al. ATP Multicenter Study. Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing. Circulation. 2012; 125(1): 31–36.
  73. Brignole M, Guieu R, Tomaino M, et al. Mechanism of syncope without prodromes with normal heart and normal electrocardiogram. Heart Rhythm. 2017; 14(2): 234–239.
  74. Connolly SJ, Sheldon R, Thorpe KE, et al. VPS II Investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA. 2003; 289(17): 2224–2229.
  75. Raviele A, Giada F, Menozzi C, et al. Vasovagal Syncope and Pacing Trial Investigators. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J. 2004; 25(19): 1741–1748.
  76. Behar S, Zissman E, Zion M, et al. Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction. SPRINT Study Group. Am J Cardiol. 1993; 72(11): 831–834.
  77. Col JJ, Weinberg SL. The incidence and mortality of intraventricular conduction defects in acute myocardial infarction. Am J Cardiol. 1972; 29(3): 344–350.
  78. Ginks WR, Sutton R, Oh W, et al. Long-term prognosis after acute anterior infarction with atrioventricular block. Br Heart J. 1977; 39(2): 186–189.
  79. Jim MH, Chan AOO, Tse HF, et al. Clinical and angiographic findings of complete atrioventricular block in acute inferior myocardial infarction. Ann Acad Med Singapore. 2010; 39(3): 185–190.
  80. Gang UJ, Hvelplund A, Pedersen S, et al. High-degree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. Europace. 2012; 14(11): 1639–1645.
  81. Chang SuM, Nagueh SF, Spencer WH, et al. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003; 42(2): 296–300.
  82. Topilski I, Sherez J, Keren G, et al. Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age. Am J Cardiol. 2006; 97(12): 1769–1775.
  83. Kappenberger LJ, Linde C, Jeanrenaud X, et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J. 1997; 18(8): 1249–1256.
  84. Maron BJ, Nishimura RA, McKenna WJ, et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation. 1999; 99(22): 2927–2933.
  85. Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol. 1997; 29(2): 435–441.
  86. Galve E, Sambola A, Saldaña G, et al. Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study. Heart. 2010; 96(5): 352–356.
  87. Megevand A, Ingles J, Richmond DR, et al. Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing. Am J Cardiol. 2005; 95(8): 991–993.

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k. ul. Świętokrzyska 73, 80–180 Gdańsk

tel.: +48 58 320 94 94, faks:+48 58 320 94 60,  e-mail: viamedica@viamedica.pl